Groundbreaking HIV study published in The Lancet

06. May 2019

The final results from the big international HIV study called PARTNER2 have now been published in the leading scientific journal The Lancet. Head of center Jens Lundgren, from the DNRF’s Center for Personalized Medicine of Infectious Complications in Immune Deficiency (PERSIMUNE), is one of the leading researchers behind the study that shows no risk of transmission from HIV-positive people when they are receiving the right treatment.

Last year, the DNRF wrote an article about the final results from the so-called PARTNER2 study; these results were presented at the AIDS2018 conference in Amsterdam. The study shows that there is zero percent risk of transmission from HIV-positive people as long as they are receiving antiretroviral treatment (ART). The final results, which have received great media attention both nationally and internationally, and have now been published in the leading scientific journal The Lancet.

The research results from PARTNER2 take their point of departure from the previous PARTNER1 study, which also found zero transmissions in the population studied. PARTNER2 is the study’s second phase, which focused specifically on the risk of transmission with unprotected sex among gay men.

The PARTNER2 study is part of CHIP, an international research collaboration run by Region Hovedstaden and Rigshospitalet, Denmark, and led by Professor Lundgren from PERSIMUNE.

Find the final scientific article in The Lancet here

Read more about the study results in a previous article from the DNRF from last year here

More information about the study can be found in a press release from CHIP here or via The Guardian here